VEGF-integrin interplay controls tumor growth and vascularization.

Area of Science:

• Molecular Biology
• Cell Biology
• Cancer Research

Background:

• Cross-talk between vascular endothelial growth factor (VEGF) and integrin cell adhesion receptors is crucial for angiogenesis and tumor development.
• The precise molecular mechanisms governing this interplay remain incompletely understood.

Purpose of the Study:

• To elucidate the mechanism by which integrin alpha v beta3 regulates VEGF production in tumor cells.
• To investigate the role of p66 Shc signaling in mediating this cross-talk.
• To determine the impact of this interaction on tumor growth and neovascularization in vivo.

Main Methods:

• Investigated integrin alpha v beta3 activation, clustering, and downstream signaling pathways.
• Assessed VEGF production in tumor cells expressing varying integrin beta3 states.
• Utilized in vivo tumor models to evaluate the effects of integrin-VEGF signaling on tumor growth and neovascularization.

Main Results:

• Integrin alpha v beta3, upon activation and clustering, signals through p66 Shc to regulate VEGF production.
• Tumors with "activatable" beta3 integrin exhibit high VEGF secretion, leading to increased neovascularization and tumor growth.
• VEGF stimulation is dependent on alpha v beta3-mediated clustering and p66 Shc phosphorylation.

Conclusions:

• Identified a novel mechanism linking beta3 integrins to VEGF production in tumor cells.
• This integrin-VEGF axis plays a significant role in promoting tumor angiogenesis and growth.
• Findings may inform the development of combined anti-integrin and anti-VEGF therapeutic strategies.